期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Quality of life issues in men undergoing androgen deprivation therapy: a review 被引量:2
1
作者 Rowan G Casey Niall M Corcoran s larry goldenberg 《Asian Journal of Andrology》 SCIE CAS CSCD 2012年第2期226-231,共6页
Androgen deprivation therapy (ADT) has been an essential treatment option for treating prostate cancer (PCa). The role for hormonal treatment initially was restricted to men with metastatic and inoperable, locally... Androgen deprivation therapy (ADT) has been an essential treatment option for treating prostate cancer (PCa). The role for hormonal treatment initially was restricted to men with metastatic and inoperable, locally advanced disease. Now it has been extended to neoadjuvant or adjuvant therapy for surgery and radiotherapy, for biochemical relapse after surgery or radiation, and even as primary therapy for non-metastatic disease. Fifty percent of PCa patients treated will receive ADT at some point. There is growing concern about the adverse effects and costs associated with more widespread ADT use. The adverse effects on quality of life (QoL), including physical, social and psychological well-being when men are androgen-deprived, may be considerable. This review examines the QoL issues in the following areas: body feminisation, sexual changes, relationship changes, cognitive and affective symptoms, fatigue, sleep disturbance, depression and physical effects. Further suggestions for therapeutic approaches to reduce these alterations are suFuzested. 展开更多
关键词 androgen deprivation therapy MEN prostate cancer quality of life
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部